Physician profile
Seilesh Babu
NPI 1528059797
$167,159.49
in general payments reported to CMS, 2019-2025
28 companies · $34K in 2025
The $34K reported for 2025 was more than what 99% of Otology & Neurotology providers received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $95.89 · 2021: $4,874 · 2022: $23K · 2023: $31K · 2024: $53K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $57K · Travel and Lodging: $29K · Food and Beverage: $11K · Grant: $10K · Honoraria: $8,000 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,000 · Education: $9.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $57,127.43 |
| Travel and Lodging | $29,064.42 |
| Food and Beverage | $11,264.99 |
| Grant | $10,000.00 |
| Honoraria | $8,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,000.00 |
| Education | $9.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Med-El Corporation | $28,003.12 | 2022-2025 | Mi1250 Synchrony 2 Flexsoft, Bci 602 Kit, Adhear Professional Kit |
| Cochlear Americas | $23,516.81 | 2019-2025 | Baha, Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Medical Device Business Services, INC. | $22,291.72 | 2019-2023 | |
| Medtronic, INC. | $20,780.53 | 2023-2025 | Nim Vital, Nim-Response, Propel |
| Integra Lifesciences Corporation | $15,760.84 | 2023-2025 | Acclarent Aera, Inspira Air, Relieva Spinplus Nav |
| Depuy Synthes Sales INC. | $13,654.86 | 2022-2023 | Trudi Nav Cable, Anspach Helix |
| Acclarent, INC | $13,137.46 | 2019-2024 | Trudi Nav Cable, Relieva Spinplus, Acclarent Navwire |
| Olympus America INC. | $12,447.97 | 2019-2025 | Orbeye Surgical Microscope, Connecting Tube, Olympus |
| Stryker Corporation | $7,254.16 | 2019-2025 | Core, 1788, Scopis Ent |
| Oticon Medical, LLC | $6,686.20 | 2019-2025 | Ponto Bone Anchored Hearing System |
| Advanced Bionics, LLC | $743.93 | 2019-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Glaxosmithkline, LLC. | $465.96 | 2022-2025 | Nucala |
| Iotamotion, INC. | $465.52 | 2023-2024 | Iotasoft Insertion System, Iotasoft |
| Intersect Ent, INC. | $391.52 | 2021-2022 | |
| Grace Medical, INC. | $327.09 | 2019-2023 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $285.55 | 2024-2025 | Restrata Wound Matrix |
| Neurent Medical Limited | $170.74 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Nsk America Corporation | $158.00 | 2025 | |
| Sanara Medtech INC. | $127.98 | 2024 | Celleraterx |
| Regeneron Healthcare Solutions, INC. | $121.82 | 2022 | |
| Aerin Medical INC. | $108.80 | 2022 | |
| Medtronic USA, INC. | $107.19 | 2019-2020 | |
| Checkpoint Surgical, INC | $50.00 | 2021 | |
| Olympus Corporation of The Americas | $37.52 | 2025 | Orbeye Surgical Microscope |
| Aesculap, INC. | $32.31 | 2022 | |
| Smith+Nephew, INC. | $17.56 | 2020 | |
| Kls-Martin L.P. | $14.33 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$9,300.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seilesh Babu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.